Deals of the day-Mergers and acquisitions

Reuters06-17
Deals of the day-Mergers and acquisitions

Adds: Surgery Partners, Nuveen; Updates: Eli Lilly

June 17 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Tuesday:

** Surgery Partners <SGRY.O> said it was unable to agree to the terms set by Bain Capital, its largest shareholder, to take the surgical facility operator private. nL4N3SK0YM

** Eli Lilly <LLY.N> will acquire gene-editing startup Verve Therapeutics <VERV.O> for up to $1.3 billion, the companies said, to boost its pipeline of experimental medicines beyond its blockbuster weight-loss and diabetes drugs. nL4N3SJ1JV

** Nuveen said it is acquiring Brooklyn Investment Group and its parent technology company, as the asset manager looks to expand its footprint in direct indexing, a fast-growing area of the investment management industry. nL4N3SJ1IU

** London-listed venture capital investor BP Marsh has acquired a 27% shareholding in Cameron Specialty, a London-based specialty MGA. nL6N3SK0DF

** Private equity firm KKR <KKR.N> said it had agreed to acquire Australian power producer Zenith Energy from a consortium comprising Australia-based Pacific Equity Partners, Canada's OPSEU Pension Trust and London-listed Foresight Group <FSGF.L>. nL4N3SJ1GP

(Compiled by Rajarshi Roy and Padmanabhan Ananthan in Bengaluru)

((Padmanabhan.Ananthan@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment